ArticleOncology reports2025

Novel tetravalent bispecific antibody, PSMA/TRAIL‑R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity.

Makoto Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.